This report analyzes the market for both traditional and connected medical devices, providing market sizing and segmentation across numerous factors. These include device type (wearable, implanted, portable, etc.), solution (diagnostic, monitoring, surgical, etc.), usage area (hospital, home, clinic, etc.), function (critical care, diagnostic, dental, etc.), durability, risk classification, manufacturing method (traditional vs. 3D printed), delivery/acquisition method, operational support model, and connectivity (Bluetooth, cellular, Wi-Fi, etc.). It also examines the therapeutic segment (cardiovascular, oncology, etc.) and industry sub-sector (drug delivery, implants, surgical instruments, etc.).
The report covers leading global medical device suppliers and service providers, along with market drivers, challenges, and the impact of converging technologies. A key focus is the rise of connected devices, including security and privacy issues. The report addresses the "new normal" post-pandemic, highlighting the surge in demand for remote medical maintenance, monitoring, and diagnostics.
Market forecasts from 2025 to 2030 are provided for various segments, including:
- Durability: Durable and Non-Durable
- Risk Classification: Class I, II, and III
- Manufacture Method: Traditional and 3D Printed
- Operational Support: Online and Field-based
- Connectivity: Bluetooth, 3G, LTE, 5G, Wi-Fi, and others
- Device Type: Wearable, Implanted, Portable, Stationary, Peripherals, and others
- Revenue Model: Sales, Revenue Sharing, Rental, Pay-per-Procedure, Support, and others
- Region: North America, Asia Pacific, Europe, Middle East & Africa, and Latin America
- Solution Type: Diagnostics, In-Patient/Outpatient Monitoring, Surgical Procedures, and Medical Treatment
- Location/Usage: Hospitals/Urgent Care, Home, Physician's Office, Clinic, and Body Wearable
- Function: Critical Care, Diagnostic, Dental, Irradiation, Lab Equipment, Monitoring, Transplants, Surgical Instruments, Treatment, and others
- Non-Durable Types: Diagnostic, Dialysis, Inhalation, Wound Care, Radiology, Infection Control, Infusion, Intubation, Personal Protection, Hypodermic, Sterilization, and others
- Delivery/Acquisition: (Traditional) - Purchased by Medical Facility/Patient/Supplier; (Connected) - DIY, Pre-integrated/Configurable Communication, and Medical Device as a Service
- Therapeutic Segment: Anesthesia, Respiratory, Audiology, Cardiovascular, Dental, Diabetes, ENT, Gastroenterology, Neurology, Nephrology, Oncology, Ophthalmology, Orthopedic, Pediatric, Skincare, Urology/Gynecology, and others
Select Report Findings:
- Class III device segment is the highest risk category with a strong CAGR of 7.4%, it is projected to nearly double, reaching $306.7 billion by 2030.
- Drug delivery devices, encompassing technologies like insulin pumps and inhalers, demonstrate a moderate growth rate of 4.2%, reaching $81.8 billion by 2030.
- The wearable device segment will achieve a Compound Annual Growth Rate (CAGR) of 10.1%, this market is projected to more than double, reaching $66.9 billion by 2030.
- The combination of DIY medical device procurement and telemedicine is an important category for suppliers as users seek greater autonomy and lower prices
- The market is witnessing an evolution as a new category of multifunctional and multipurpose medical devices is emerging that incorporate fitness and healthcare